A friend on Tradingview gave me a tip the other day when he said "GWPH is cheap right now. Temporary health industry dip. Great long term stock. " Well I finally got off my lqzy a$$ and looked it up today to find an evaluation that read as follows: "GW Pharmaceuticals Plc lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.81% during the next 3 months and, with 90% probability hold a price between $181.57 and $221.58 at the end of this period....Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate." (Stockinvest.us) So I looked at the chart and said hmmmm, "that's a little pricey for me" and looked for a reason to say no (this is where options come in handy); I can't find one can you? Did I get in - the second 90% probability rating I found in the same day - you know I did :) Thanks for the tip Barkworth! Good luck with your trades!
BTW that bullish candlestick pattern is Three White Soilders
After a rough week it's at least up considerably from where we started in spite of the US China trade war...looks good to me :)
Ron-V
⋅
light em up boys :)....I think this one's a real winner
Ron-V
⋅
This again appears again to be a good entry point looking back. Three white soldiers and rejection occurred around 173.00 a few days ago. Yesterday closed with a bullish engulfing candle and today we find ourselves bumping up against the same area. If we close above it, it will be a very good sign since after that the 1st point of resistance would be 176.48 and then 179.80.
Ron-V
⋅
ouch....rough entry
Barkworth
⋅
You got in. Well done! Good vibes, this is how a community is intended to work :-)
When pointed it out to you, it was trading at $1.55. It had just closed a gap down from a spike a few weeks back, and seemed like a potential to look for an entry. I had the same feeling as you: a little pricey by market cap. But the EU hasn't even approved Epidiolex yet. Once that will happen, we may be looking at another big leg up. That drug is a real winner.